JP2018048143A5 - - Google Patents

Download PDF

Info

Publication number
JP2018048143A5
JP2018048143A5 JP2017183651A JP2017183651A JP2018048143A5 JP 2018048143 A5 JP2018048143 A5 JP 2018048143A5 JP 2017183651 A JP2017183651 A JP 2017183651A JP 2017183651 A JP2017183651 A JP 2017183651A JP 2018048143 A5 JP2018048143 A5 JP 2018048143A5
Authority
JP
Japan
Prior art keywords
ring
group
methyl
urea
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017183651A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018048143A (ja
JP6627835B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018048143A publication Critical patent/JP2018048143A/ja
Publication of JP2018048143A5 publication Critical patent/JP2018048143A5/ja
Application granted granted Critical
Publication of JP6627835B2 publication Critical patent/JP6627835B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017183651A 2014-10-24 2017-09-25 Kcnq2〜5チャネル活性化剤 Expired - Fee Related JP6627835B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014217540 2014-10-24
JP2014217540 2014-10-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016555419A Division JP6217866B2 (ja) 2014-10-24 2015-10-23 Kcnq2〜5チャネル活性化剤

Publications (3)

Publication Number Publication Date
JP2018048143A JP2018048143A (ja) 2018-03-29
JP2018048143A5 true JP2018048143A5 (enExample) 2018-11-15
JP6627835B2 JP6627835B2 (ja) 2020-01-08

Family

ID=55761020

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016555419A Active JP6217866B2 (ja) 2014-10-24 2015-10-23 Kcnq2〜5チャネル活性化剤
JP2017183651A Expired - Fee Related JP6627835B2 (ja) 2014-10-24 2017-09-25 Kcnq2〜5チャネル活性化剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016555419A Active JP6217866B2 (ja) 2014-10-24 2015-10-23 Kcnq2〜5チャネル活性化剤

Country Status (17)

Country Link
US (4) US9809544B2 (enExample)
EP (1) EP3210969B1 (enExample)
JP (2) JP6217866B2 (enExample)
KR (1) KR20170076673A (enExample)
CN (1) CN107108485B (enExample)
AU (1) AU2015336458B2 (enExample)
BR (1) BR112017008178A2 (enExample)
CA (1) CA2965467A1 (enExample)
ES (1) ES2871673T3 (enExample)
IL (1) IL251827B (enExample)
MX (1) MX373603B (enExample)
PH (1) PH12017500737B1 (enExample)
RU (1) RU2712163C2 (enExample)
SG (1) SG11201703284XA (enExample)
TW (1) TWI664166B (enExample)
WO (1) WO2016063990A1 (enExample)
ZA (1) ZA201703498B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2712163C2 (ru) 2014-10-24 2020-01-24 Оно Фармасьютикал Ко., Лтд. Активатор kcnq2-5 каналов
ES2866324T3 (es) * 2016-04-22 2021-10-19 Ono Pharmaceutical Co Derivados de 1-(1-hidroxi-2,3-dihidro-1H-inden5-il)-urea y compuestos similares como activadores del canal KCNQ2-5 para el tratamiento de la disuria
JP6197971B1 (ja) * 2016-04-22 2017-09-20 小野薬品工業株式会社 Kcnq2〜5チャネル関連疾患の予防および/または治療剤
SG11201809184VA (en) * 2016-04-22 2018-11-29 Ono Pharmaceutical Co Crystal polymorphism of kcnq2-5 channel activator
US11376253B2 (en) * 2017-12-21 2022-07-05 Kyorin Pharmaceutical Co., Ltd. Agent for treating nocturnal pollakiuria
CN109232380B (zh) * 2018-10-22 2021-08-10 新乡市润宇新材料科技有限公司 一种4-溴咔唑的合成方法
CN109232383B (zh) * 2018-12-04 2022-02-01 河南省科学院高新技术研究中心 一种合成4-溴咔唑的方法
CN113692304B (zh) * 2019-02-06 2025-03-18 礼来公司 作为kcnq增强剂的1-((2-(2,2,2-三氟乙氧基)吡啶-4-基)甲基)脲衍生物
AR122739A1 (es) * 2020-06-25 2022-10-05 Idorsia Pharmaceuticals Ltd Derivados de ciclobutil-urea
JP7728367B2 (ja) * 2021-06-14 2025-08-22 スコーピオン・セラピューティクス・インコーポレイテッド がんを処置するために使用され得る尿素誘導体

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH623044A5 (en) * 1974-12-02 1981-05-15 Scherico Ltd Process for the preparation of novel anilino-2-oxazolines
ES442992A1 (es) * 1974-12-02 1977-08-01 Scherico Ltd Un procedimiento para preparar 2-anilino-oxazolinas.
US4058612A (en) * 1974-12-02 1977-11-15 Schering Corporation 6-(Polyhaloisopropyl)quinazoline-2,4-diones
US7385063B2 (en) * 2001-01-26 2008-06-10 Chugai Seiyaku Kabushiki Kaisha Method for preparing imidazole derivatives
US7524969B2 (en) * 2001-01-26 2009-04-28 Chugai Seiyaku Kabushiki Kaisha Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
JP2003192660A (ja) * 2001-12-26 2003-07-09 Bayer Ag 尿素誘導体
EP1461311A2 (en) * 2001-12-26 2004-09-29 Bayer HealthCare AG Urea derivatives as vr1-antagonists
US7399866B2 (en) 2003-01-14 2008-07-15 Cytokinetics, Inc. Compounds, compositions, and methods
UA89503C2 (uk) 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
AU2006322461A1 (en) * 2005-09-09 2007-06-14 H. Lundbeck A/S Pyrimidine derivatives and their use as KCNQ potassium channels openers
AR070513A1 (es) * 2007-08-01 2010-04-14 Lundbeck & Co As H Uso de abridores de canales de potasio kcnq para reducir los sintomas o tratar desordenes o afecciones en las cuales se encuentra anulado el sis-tema dopaminergico como por ejemplo esquizofrenia y trastorno depresivo mayor
JP2010037311A (ja) 2008-08-08 2010-02-18 Bayer Cropscience Ag 新規殺虫性アシルアミノベンズアミド誘導体
WO2010065333A1 (en) 2008-12-01 2010-06-10 Lexicon Pharmaceuticals, Inc. 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds for the treatment of osteoporosis
TWI475020B (zh) * 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
WO2011085351A2 (en) * 2010-01-11 2011-07-14 The Johns Hopkins University Method of treating kcnq related disorders
MX2012007661A (es) 2010-01-11 2012-08-01 Inotek Pharmaceuticals Corp Combinacion, kit y metodo para reducir la presion intraocular.
US20130029962A1 (en) * 2011-07-26 2013-01-31 Gruenenthal Gmbh Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
SI2773633T1 (sl) * 2011-11-02 2017-11-30 Boehringer Ingelheim International Gmbh Heterociklične spojine, zdravila, ki vsebujejo te spojine, njihova uporaba in postopki za njihovo pripravo
RU2712163C2 (ru) * 2014-10-24 2020-01-24 Оно Фармасьютикал Ко., Лтд. Активатор kcnq2-5 каналов

Similar Documents

Publication Publication Date Title
JP2018048143A5 (enExample)
RU2017117566A (ru) Активатор kcnq2-5 каналов
RU2011108281A (ru) Трипиридилкарбоксамидные антагонисты орексиновых рецепторов
JP2015529224A5 (enExample)
JP2014511892A5 (enExample)
JP2017533968A5 (enExample)
JP2015537015A5 (enExample)
JP2017528498A5 (enExample)
JP2012507566A5 (enExample)
JP2016522172A5 (enExample)
JP2016516699A5 (enExample)
JP2017528467A5 (enExample)
RU2014113679A (ru) N-(2-амино-6,6-дифтор-4,4а,5,6,7,7а-гексагидро-циклопента[e][1,3]оксазин-4-ил)-фенил)-амиды в качестве ингибиторов бета-секретазы 1
JP2016505512A5 (enExample)
JP2016525075A5 (enExample)
JP2018522823A5 (enExample)
JP2017514855A5 (enExample)
RU2017101829A (ru) Пиразоловые соединения в качестве модуляторов fshr и пути их применения
RU2017116196A (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1
JP2017517538A5 (enExample)
JP2019518770A5 (enExample)
RU2018114077A (ru) Биарильное производное и содержащее его лекарственное средство
JP2014510147A5 (enExample)
JP2013527847A5 (enExample)
RU2016104844A (ru) Производные n-мочевино замещенных аминокислот как модуляторы формил-пептидного рецептора